Rigel Pharmaceuticals Inc (NASDAQ: RIGL) stock enjoyed a major increase of 12.0% on 7/11/24. The shares closed at $9.62. However, trading volume in this advance was normal at 83% of normal. The stock has been weak relative to the market over the last nine months but has risen 14.3% during the last week.
Current PriceTarget Research Rating
RIGL is expected to be a modest Value Eraser reflecting capital returns that are forecasted to be below the cost of capital.
Rigel Pharmaceuticals is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment